In this study, to study the pathological role of Myc in cardiomyopathy and heart failure, we developed and characterized a newly established bi-transgenic mouse (MHC-Myc), which expresses Myc specifically in cardiomyocytes in a doxycycline-dependent manner. Here, MYC is linked to heart failure.